NXTS
Nexentis Technologies Inc.Company Information
- Company Name
- Nexentis Technologies Inc.
- CIK
- CIK0001789192
- Category
- <br>Emerging growth company
- Ticker: Exchange
- NXTS: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- NXTS
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-12-23
- Last sale
- 2026-01-29
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 127
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 18,221
- Shares outstanding
- 816,136
- Ownership
- 2.23%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -11.79%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 8 | 4 | 4 | 6 | 3 | 3 | 2 | 3 | 4 | 3 | 4 | 2 | ||||||
| Restricted Cash Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Marketable Securities Current | 1 | 2 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 10 | 8 | 6 | 9 | 5 | 4 | 3 | 3 | 5 | 4 | 5 | 3 | ||||||
| Inventory Net | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Current | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Prepaid Expense Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Equity Method Investments | - | - | - | - | - | 1 | 1 | 1 | 2 | 2 | 2 | 2 | ||||||
| Other Assets Noncurrent | - | 3 | 3 | 2 | 2 | 1 | 1 | 1 | - | - | - | - | ||||||
| Goodwill | - | - | 6 | - | - | - | - | - | - | - | - | - | ||||||
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 3 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Long Term Investments | 1 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 4 | 4 | 4 | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 19 | 16 | 20 | 11 | 8 | 7 | 5 | 6 | 7 | 6 | 7 | 5 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Short Term Borrowings | 0 | 0 | 1 | 1 | - | - | - | - | 1 | - | - | - | ||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 3 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | ||||||
| Other Liabilities Current | 3 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | - | ||||||
| Line Of Credit | 0 | 0 | 0 | 0 | 1 | 1 | - | - | - | - | - | - | ||||||
| Derivative Liabilities Noncurrent | 8 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Contingent Consideration Classified As Equity Fair Value Disclosure | 0 | 1 | 2 | - | - | - | - | - | - | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 1 | 1 | 1 | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 17 | 4 | 5 | 2 | 2 | 4 | 1 | 1 | 2 | 1 | 1 | 1 | ||||||
| Common Stock Value | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | - | 0 | 0 | - | - | - | ||||||
| Additional Paid In Capital | 58 | 58 | 55 | 49 | 46 | 40 | 39 | 39 | 37 | 36 | 36 | 32 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 2 | 13 | 16 | 9 | 6 | 4 | 5 | 5 | 6 | 6 | 6 | 5 | ||||||
| Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -56 | -45 | -39 | -40 | -40 | -36 | -35 | -33 | -31 | -30 | -29 | -28 | ||||||
| Minority Interest | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | ||||||
| Liabilities And Stockholders Equity | 19 | 16 | 20 | 11 | 8 | 7 | 5 | 6 | 7 | 6 | 7 | 5 | ||||||
| Allowance For Doubtful Accounts Premiums And Other Receivables | - | - | - | 0 | 0 | 0 | 0 | - | - | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Common Stock Shares Authorized | 495 | 495 | 495 | 495 | 495 | 495 | 495 | 495 | 495 | 495 | 495 | - | ||||||
| Common Stock Shares Issued | 1 | 1 | 3 | 1 | 30 | 18 | 0 | 10 | 4 | 3 | 3 | - | ||||||
| Shares Outstanding | 1 | 1 | 3 | 1 | 30 | 18 | 0 | 10 | 4 | 3 | 3 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNexentis Technologies Inc. (NXTS) — SEC Financial Statements & Analysis
Nexentis Technologies Inc. (NXTS) is a pharmaceutical preparations company, incorporated in NV. Nexentis Technologies Inc. trades on Nasdaq as: NXTS. Nexentis Technologies Inc. (NXTS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, On profitability, Nexentis Technologies Inc. posts a gross margin of 88.94%, an operating margin of -560000.00%, a net margin of -802600.00%, a Return on Equity (ROE) of -437.80%, a Return on Assets (ROA) of -121.40%, and a Return on Invested Capital (ROIC) of -242.81%. Per share, it reports EPS of $-19.67, diluted EPS of $-19.67, free cash flow per share of $-5.52, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -99.07% year-over-year, net income growth of 71.90% year-over-year, and EPS growth of -78.55% year-over-year. On the balance sheet, it maintains a current ratio of 3.72x, a quick ratio of 3.47x, working capital of $7.60M, a debt-to-equity ratio of 9.49x, a debt ratio of 0.9, free cash flow of $-4.50M (TTM), and net debt of $-7.45M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-19.67
- ROE TTM
- -437.80%
- ROA TTM
- -121.40%
- Debt To Equity
- 9.49x
- Free Cash Flow TTM
- $-4.50M
- Net Revenue TTM Growth 1Y
- -99.07%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Nexentis Technologies Inc. in?
Nexentis Technologies Inc. (NXTS) operates in the Pharmaceutical Preparations industry.
What exchange does NXTS trade on?
Nexentis Technologies Inc. (NXTS) trades on the Nasdaq.
Where is Nexentis Technologies Inc. incorporated?
Nexentis Technologies Inc. is incorporated in NV.
When was Nexentis Technologies Inc. (NXTS)'s most recent SEC filing?
Nexentis Technologies Inc. (NXTS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is NXTS's EPS (earnings per share)?
Nexentis Technologies Inc. (NXTS)'s trailing twelve month EPS is $-19.67 as of 2026-06-30.
What is NXTS's ROE (return on equity)?
Nexentis Technologies Inc. (NXTS)'s trailing twelve month Return on Equity (ROE) is -437.80% as of 2026-06-30.
What is NXTS's ROA (return on assets)?
Nexentis Technologies Inc. (NXTS)'s trailing twelve month Return on Assets (ROA) is -121.40% as of 2026-06-30.
What is NXTS's ROIC (return on invested capital)?
Nexentis Technologies Inc. (NXTS)'s trailing twelve month Return on Invested Capital (ROIC) is -242.81% as of 2026-03-31.